Detalhe da pesquisa
1.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071508
2.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314967
3.
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
J Rheumatol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621792
4.
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
J Rheumatol
; 51(4): 378-389, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224992
5.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100351
6.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Rheumatology (Oxford)
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738257
7.
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Ann Rheum Dis
; 81(6): 780-785, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058229
8.
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
Ann Rheum Dis
; 81(10): 1358-1366, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705376
9.
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
Rheumatology (Oxford)
; 61(9): 3799-3807, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940840
10.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
Rheumatology (Oxford)
; 61(12): 4741-4751, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323903
11.
Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2.
Int J Mol Sci
; 24(1)2022 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36613655
12.
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.
Ann Rheum Dis
; 80(11): 1410-1418, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083206
13.
The cut-off values for the intima-media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries.
Rheumatology (Oxford)
; 60(3): 1346-1352, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32944770
14.
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.
Rheumatology (Oxford)
; 60(2): 820-828, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810263
15.
Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis.
Int J Mol Sci
; 22(12)2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204585
16.
Risk factors for severe cranial ischaemic complications in giant cell arteritis.
Rheumatology (Oxford)
; 59(10): 2953-2959, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125431
17.
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
Rheumatology (Oxford)
; 59(9): 2455-2461, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960053
18.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665497
19.
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ann Rheum Dis
; 78(11): 1536-1544, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431486
20.
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
Ann Rheum Dis
; 77(9): 1276-1282, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29730637